Creative Financial Designs’s Aimmune Therapeutics AIMT Stock Holding History

Creative Financial Designs’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-75	Closed	-$3K	–	1333
2020 Q3	$3K	Hold	75	–	–	﹤0.01%	1069
2020 Q2	$1K	Buy	+75	New	+$1.27K	﹤0.01%	1141

Creative Financial Designs's AIMT Position: Q4 2020 in Review

Creative Financial Designs sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 75 shares — an estimated $3K sold.

Creative Financial Designs first reported a position in AIMT in Q2 2020 and held it in 2 quarters. The position peaked at $3K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

Creative Financial Designs reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
Creative Financial Designs sold 75 Aimmune Therapeutics shares in Q4 2020, an estimated $3K.
Creative Financial Designs first reported a position in Aimmune Therapeutics in Q2 2020 and held it in 2 quarters.
Creative Financial Designs's Aimmune Therapeutics position peaked at $3K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on Creative Financial Designs's 13F filing for Q4 2020, filed 8 Jan 2021.